Publications by authors named "Michael Pinn"

Claim this Profile
A
Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis.
Yu-Min Chuang, Liangmei He, Michael L Pinn, Ya-Chea Tsai, Max A Cheng

Cell Mol Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
Yu-Min Chuang, Noton K Dutta, James T Gordy, Victoria L Campodónico, Michael L Pinn

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
Yu-Min Chuang, Michael L Pinn, Petros C Karakousis, Chien-Fu Hung

Front Cell Infect Microbiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Dutta et al., "Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice".
Noton K Dutta, Michael L Pinn, Petros C Karakousis

Antimicrob Agents Chemother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice.
Noton K Dutta, Michael L Pinn, Petros C Karakousis

Antimicrob Agents Chemother· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
Jean-Philippe Lanoix, Rokeya Tasneen, Paul O'Brien, Jansy Sarathy, Hassan Safi, Michael Pinn

Antimicrob Agents Chemother· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin adjunctive therapy shortens the duration of TB treatment in mice.
Noton K Dutta, Natalie Bruiners, Michael L Pinn, Matthew D Zimmerman, Brendan Prideaux

J Antimicrob Chemother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacterial Protein Tyrosine Phosphatases A and B Inhibitors Augment the Bactericidal Activity of the Standard Anti-tuberculosis Regimen.
Noton K Dutta, Rongjun He, Michael L Pinn, Yantao He, Francis Burrows

ACS Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.
Ciaran Skerry, Michael L Pinn, Natalie Bruiners, Richard Pine, Maria L Gennaro

J Antimicrob Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
Noton K Dutta, Michael L Pinn, Petros C Karakousis

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.
Noton K Dutta, Michael L Pinn, Petros C Karakousis

Antimicrob Agents Chemother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs.
Ciaran Skerry, Supriya Pokkali, Michael Pinn, Nicholas A Be, Jamie Harper

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
Noton K Dutta, Abdullah Alsultan, Thomas J Gniadek, Deborah A Belchis, Michael L Pinn

Antimicrob Agents Chemother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.
Noton K Dutta, Michael L Pinn, Ming Zhao, Michelle A Rudek, Petros C Karakousis

J Antimicrob Chemother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Noton K Dutta, Peter B Illei, Charles A Peloquin, Michael L Pinn, Khisimuzi E Mdluli

Antimicrob Agents Chemother· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
Zahoor Ahmad, Mostafa M Fraig, Michael L Pinn, Sandeep Tyagi, Eric L Nuermberger

J Antimicrob Chemother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.
Zahoor Ahmad, Michael L Pinn, Eric L Nuermberger, Charles A Peloquin, Jacques H Grosset

J Antimicrob Chemother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
Zahoor Ahmad, Eric L Nuermberger, Rokeya Tasneen, Michael L Pinn, Kathy N Williams

J Antimicrob Chemother· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
Zahoor Ahmad, Lee G Klinkenberg, Michael L Pinn, Mostafa M Fraig, Charles A Peloquin

J Infect Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental ocular tuberculosis in guinea pigs.
Narsing A Rao, Thomas A Albini, Mirnalini Kumaradas, Michael L Pinn, Mostafa M Fraig

Arch Ophthalmol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Weibo Zhou, Wan Fang Han, Leslie E Landree, Jagan N Thupari, Michael L Pinn

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.
Jill M McFadden, Susan M Medghalchi, Jagan N Thupari, Michael L Pinn, Aravinda Vadlamudi

J Med Chem· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Patricia M Alli, Michael L Pinn, Elizabeth M Jaffee, Jill M McFadden, Francis P Kuhajda

Oncogene· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
Yajun Tu, Jagan N Thupari, Eun-Kyoung Kim, Michael L Pinn, Timothy H Moran

Endocrinology· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
Eun-Kyoung Kim, Ian Miller, Susan Aja, Leslie E Landree, Michael Pinn

J Biol Chem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis